as of 11-11-2026 2:37pm EST
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 2.6B | IPO Year: | 2020 |
| Target Price: | $5.60 | AVG Volume (30 days): | 4.2M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | 38.03 |
| 52 Week Low/High: | $1.58 - $5.59 | Next Earning Date: | 11-04-2026 |
| Revenue: | $1,924,308,000 | Revenue Growth: | 40.34% |
| Revenue Growth (this year): | 55.33% | Revenue Growth (next year): | 22.64% |
| P/E Ratio: | 44.68 | Index: | |
| Free Cash Flow: | -68977000.0 | FCF Growth: | N/A |
Chief Legal Officer
Avg Cost/Share
$4.66
Shares
19,275
Total Value
$89,821.50
Owned After
1,573,423
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$4.41
Shares
4,066
Total Value
$17,931.06
Owned After
2,770,351
SEC Form 4
Chief Legal Officer
Avg Cost/Share
$4.68
Shares
14,673
Total Value
$68,669.64
Owned After
1,573,423
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$4.68
Shares
62,176
Total Value
$290,983.68
Owned After
9,078,334
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$4.68
Shares
18,273
Total Value
$85,517.64
Owned After
2,770,351
SEC Form 4
CEO, Counterpart Health
Avg Cost/Share
$4.68
Shares
23,627
Total Value
$110,574.36
Owned After
1,042,072
SEC Form 4
Interim CFO
Avg Cost/Share
$4.68
Shares
4,591
Total Value
$21,485.88
Owned After
1,244,935
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$4.63
Shares
2,006
Total Value
$9,287.78
Owned After
2,770,351
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$4.42
Shares
8,750
Total Value
$38,675.00
Owned After
2,770,351
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$4.56
Shares
1,921
Total Value
$8,759.76
Owned After
2,770,351
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Soares Karen | CLOV | Chief Legal Officer | Oct 20, 2026 | Sell | $4.66 | 19,275 | $89,821.50 | 1,573,423 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 19, 2026 | Sell | $4.41 | 4,066 | $17,931.06 | 2,770,351 | |
| Soares Karen | CLOV | Chief Legal Officer | Oct 15, 2026 | Sell | $4.68 | 14,673 | $68,669.64 | 1,573,423 | |
| Toy Andrew | CLOV | Chief Executive Officer | Oct 15, 2026 | Sell | $4.68 | 62,176 | $290,983.68 | 9,078,334 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 15, 2026 | Sell | $4.68 | 18,273 | $85,517.64 | 2,770,351 | |
| Wai Conrad | CLOV | CEO, Counterpart Health | Oct 15, 2026 | Sell | $4.68 | 23,627 | $110,574.36 | 1,042,072 | |
| THORNTON JOSEPH CLAY | CLOV | Interim CFO | Oct 15, 2026 | Sell | $4.68 | 4,591 | $21,485.88 | 1,244,935 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 7, 2026 | Sell | $4.63 | 2,006 | $9,287.78 | 2,770,351 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 5, 2026 | Sell | $4.42 | 8,750 | $38,675.00 | 2,770,351 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Sep 17, 2026 | Sell | $4.56 | 1,921 | $8,759.76 | 2,770,351 |
SEC 8-K filings with transcript text
Nov 4, 2026 · 100% conf.
1D
-7.38%
$3.97
Act: -4.07%
5D
-11.97%
$3.78
20D
-10.39%
$3.84
2 a3q26exx991xearningsrelease.htm
Document
Exhibit 99.1
Clover Health Reports Third Quarter 2026 Results
Business Highlights:
•Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth
•Improved Full Year 2026 guidance across all metrics
•2027 AEP tracking well, with significant growth due to strong product positioning in core markets
•Clover’s flagship PPO, representing ~98% of current membership, received a 5 Star rating for Payment Year 2028
Financial Results:
•Third quarter 2026 GAAP Net Income of $6 million, an improvement of $31 million year-over-year
•Third quarter 2026 Medicare Advantage membership of 158,907, up 45% year-over-year, and Total revenues of $759 million, up 53% year-over-year
•Third quarter 2026 Consolidated Gross Profit of $130 million, up 77% year-over-year, and Adjusted EBITDA of $16 million, up $14 million year-over-year
Improved Full Year 2026 Guidance:
•Average Medicare Advantage membership of 157,000 - 158,000, representing 47% growth year-over-year at the midpoint
•Total revenues between $2.97 billion and $3.00 billion, representing 55% growth year-over-year at the midpoint
•GAAP Net Income between $25 million and $35 million
•Consolidated Gross Profit between $540 million and $555 million, representing 54% growth year-over-year at the midpoint
•Adjusted EBITDA profitability between $75 million and $85 million
WILMINGTON, Del. – November 4, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the third quarter 2026. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.
“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model,” said Clover Health CEO Andrew Toy. "Through Clover Assistant, we are committed to delivering better clinical quality and lower total cost of care. We are pleased that this continues to show up in our results, with ~98% of our members enrolled in our 5 Star rated PPO for Payment Year 2028, alongside our third consecutive year of nation-leading HEDIS performance.”
"In 2026, Clover is on track to have grown significantly and expects to deliver its first full year of GAAP Net Income profitability,” said Clover Health CFO Clay Thornton. “With our largest member cohorts maturing, continued operating leverage, and strong Star ratings performance, we believe we are well positioned for meaningful earnings expansion in 2027.”
1
Key Company highlights are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Dollars in Millions20262025Change (%)20262025Change (%)
Consolidated:
Total revenues$759.3 $496.7 52.9 %$2,251.7 $1,436.6 56.7 %
Consolidated Gross profit(1) $129.8 $73.2 77.3 %$442.4 $281.7 57.0 %
Salaries and benefits plus General and administrative expenses ("SG&A")$122.8 $97.1 26.5 %$378.9 $316.6 19.7 %
Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A")(2) $113.8 $71.1 60.1 %$345.2 $236.7 45.8 %
Adjusted SG&A as a % of Total revenues15.0 %14.3 %70 bps15.3 %16.5 %(120 bps)
Net income (loss)$6.4 $(24.4)N/A*$61.8 $(36.2)N/A*
Adjusted EBITDA(2) $16.1 $2.1 666.7 %$97.2 $45.0 116.0 %
Adjusted Net income(2) $15.4 $1.7 805.9 %$95.5 $43.7 118.5 %
Total cash, cash equivalents, and investments$512.6 $395.9 29.5 %$512.6 $395.9 29.5 %
Insurance Segment:
Average Medicare Advantage membership(5) 158,383 108,231 46.3 %156,610 105,228 48.8 %
Insurance revenue$748.8 $479.1 56.3 %$2,230.7 $1,405.9 58.7 %
Insurance net medical claims incurred$654.1 $428.9 52.5 %$1,879.5 $1,191.0 57.8 %
Insurance BER(3) 91.1 %93.5 %(240 bps)88.4 %89.4 %(100 bps)
1,2,3,4,5
2026 Financial Guidance
Current 2026 GuidancePrevious 2026 Guidance
Total revenues$2.97 billion - $3.00 billion$2.92 billion - $3.00 billion
GAAP Net income$25 million - $35 million$20 million - $35 million
Consolidated Gross profit(1) $540 million - $555 million$525 million - $555 million
Adjusted EBITDA(4) $75 million - $85 million$70 million - $85 million
Average Medicare Advantage membership157,000 - 158,000156,000 - 158,000
Lives under Clover Management
September 30, 2026September 30, 2025
Insurance members158,907 109,226
*Not presented as a % change because the current or prior period amount is zero or the amount for the line item changed from a gain to a loss (or vice versa) and thus yields a result that is not meaningful.
1 Consolidated Gross profit (Non-GAAP) is a non-GAAP financial measure and is calculated by taking net income (loss) before salaries and benefits, general and administrative expenses, depreciation and amortization, premium deficiency reserve expense, restructuring costs, imp
Aug 5, 2026 · 100% conf.
1D
+0.25%
$4.20
Act: +9.59%
5D
+13.75%
$4.76
20D
+11.24%
$4.66
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.e618d017.1786368612.cadddbd4
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
May 6, 2026 · 100% conf.
1D
-0.75%
$2.66
Act: +5.22%
5D
+10.01%
$2.95
Act: +32.46%
20D
+3.71%
$2.78
Act: +48.88%
2 a1q26exx991xearningsrelease.htm
Document
Exhibit 99.1
Clover Health Reports First Quarter 2026 Results
Business Highlights:
•Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross Profit
•Market-leading Medicare Advantage membership growth with underlying trends tracking in line with expectations
•Expect to meet or exceed full year 2026 outlook across all metrics, including achieving first full year GAAP Net Income profitability
Financial Results:
•First quarter 2026 GAAP Net Income of $27 million, an improvement of $29 million year-over-year
•First quarter 2026 Medicare Advantage membership of 155,773, up 51% year-over-year, and Total revenues of $749 million, up 62% year-over-year
•First quarter 2026 Consolidated Gross Profit of $160 million, up 47% year-over-year, and Adjusted EBITDA of $40 million, up 56% year-over-year
Full Year 2026 Guidance:
•Average Medicare Advantage membership of 154,000 - 158,000, representing 46% growth year-over-year at the midpoint
•Total revenues between $2.81 billion and $2.92 billion, representing 49% growth year-over-year at the midpoint
•Consolidated Gross Profit between $470 million and $510 million, representing 38% growth year-over-year at the midpoint
•Adjusted EBITDA profitability between $50 million and $70 million
•GAAP Net Income between $0 million and $20 million
WILMINGTON, Del. – May 6, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the first quarter 2026. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.
“Our results demonstrate the differentiated model we have built to drive growth and profitability while expanding access to high-quality, affordable care through a wide-network PPO,” said Clover Health CEO Andrew Toy. “During the first quarter, we delivered strong performance across key metrics, driven by deeper clinical engagement, with Clover Assistant supporting earlier intervention and better outcomes for our members. As we continue to scale our technology to reach more members, we expect to achieve our first full year of GAAP Net Income profitability in 2026.”
“We achieved positive GAAP Net Income in the first quarter of 2026 while continuing to grow at a market-leading rate,” said Clover Health Interim CFO Clay Thornton. “Results are developing in line with our expectations, and we are encouraged by early medical cost trend indicators across both new and returning cohorts. We expect to meet or exceed our full year 2026 outlook across all metrics, including our expectation to deliver GAAP Net Income profitability.”
1
Key Company highlights are as follows:
Three Months Ended March 31,
Dollars in Millions20262025Change (%)
Consolidated:
Total revenues $749.2 $462.3 62.1 %
Consolidated Gross profit(1) $159.5 $108.9 46.5 %
Salaries and benefits plus General and administrative expenses ("SG&A")$131.7 $109.7 20.1 %
Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A")(2) $119.3 $83.1 43.6 %
Adjusted SG&A as a % of Total revenues15.9 %18.0 %(210) bps
Net income (loss)
Adjusted EBITDA(2) $40.3 $25.8 56.2 %
Adjusted Net income(2) $39.7 $25.3 56.9 %
Total cash, cash equivalents, and investments$418.2 $390.8 7.0 %
Insurance Segment:
Average Medicare Advantage membership(5) 154,607 101,959 51.6 %
Insurance revenue$744.2 $456.9 62.9 %
Insurance net medical claims incurred$610.0 $367.9 65.8 %
Insurance BER(3) 86.5 %86.1 %40 bps
1,2,3,4,5
2026 Financial Guidance
2026 Guidance
Total revenues $2.81 billion - $2.92 billion
Consolidated Gross profit(1) $470 million - $510 million
Adjusted EBITDA(4) $50 million - $70 million
GAAP Net income$0 million - $20 million
Average Medicare Advantage membership154,000 - 158,000
Lives under Clover Management
March 31, 2026March 31, 2025
Insurance members155,773 103,418
Earnings Conference Call Details
*Not presented as a % change because the current or prior period amount is zero or the amount for the line item changed from a gain to a loss (or vice versa) and thus yields a result that is not meaningful.
1 Consolidated Gross profit (Non-GAAP) is a non-GAAP financial measure and is calculated by taking net income (loss) before salaries and benefits, general and administrative expenses, depreciation and amortization, premium deficiency reserve expense, restructuring costs, impairment of goodwill and other intangible assets, interest expense, change in fair value of warrants, and loss on investment. A reconciliation of Consolidated Gross profit (Non-GAAP) to Net income, the most directly comparable GAAP measure is provided in the table immediately following the consolidated financial statements below. A reconciliation of projected Consolidated Gr
See how CLOV stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.